For Emergency Referral or to Transfer a patient to Erlanger Medical Center please call 423.778.8100

For Patient Transfer to Memorial Hospital, please call 423.495.8618

Trained personnel are always on-call, including a Neurologist or a Heart and Stroke physician.

Please have the following information available:
• Will Lifeforce be needed?
• Time of onset
• Has a CT been performed?

SELECTING THE RIGHT TREATMENT CENTER FOR ACUTE STROKES

Chattanooga’s ER facilities have in place ACUTE STROKE TREATMENT PROTOCOLS offering a range of interventional windows. Please consult the guide below to choose a Medical Center or Hospital ER that most closely matches your patient’s needs.

TWELVE-HOUR WINDOW TREATMENT FACILITIES

ERLANGER MEDICAL CENTER offers interventional therapy for acute stroke patients up to 12 hours from the on-set of symptoms. A combination regimen called the Fujisawa Study is available to patients who qualify for participation. Treatment consists of administering the clot-buster drug t-PA, combined with a compound FK506 that may provide neuro-protection during acute stroke. For details on Fujisawa, please click here.

SIX-HOUR WINDOW TREATMENT FACILITIES

ERLANGER MEDICAL CENTER and MEMORIAL HOSPITAL both accept patients whose symptoms manifest within a six-hour time frame. Treatment protocols are approved at these facilities for administering t-PA INTRAVENOUSLY or INTRA-ARTERIALLY. Qualified patient candidates may also receive a potent neuro-protective agent under the aegis of the on-going RREACT/ ONO study. Please click here for further information on this neuro-protective compound.

THREE-HOUR WINDOW TREATMENT FACILITIES

ERLANGER MEDICAL CENTER, MEMORIAL HOSPITAL and the PARKRIDGE MEDICAL CENTER are all approved to provide INTRAVENOUS t-PA to patients presenting with acute strokes. The treatment window in these cases is three hours from the on-set of a stroke emergency

Please visit the Erlanger, Memorial and Parkridge Medical Centers for more information on each facility.